Pharmaceutical care program for patients with reactive airways disease

M. Weinberger, M. D. Murray, D. G. Marrero, N. Brewer, M. Lykens, L. E. Harris, W. M. Tierney

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

A pharmaceutical care program for patients with reactive airways disease (RAD) is described. A pharmaceutical care program for patients with RAD was developed and implemented at 36 CVS pharmacies. The impact on patient outcomes, pharmacist job satisfaction, and other variables is currently being evaluated in a controlled trial with more than 1100 patient enrollees. Guiding the program are the beliefs that pharmacists must have clinically relevant, patient-specific data to provide appropriate care; that pharmacists must have adequate training to provide pharmaceutical care; that the program must be sensitive to organizational barriers, particularly time demands; and that there must be ongoing support for the program. The program has five components: (1) computer display of patient-specific data for patients enrolled in the study, (2) distribution of tailored patient education materials, (3) use of a resource guide to facilitate the implementation of pharmaceutical care, (4) strategies to reinforce and facilitate the program, and (5) pharmacist training. While developed for community pharmacies, the program is applicable to most ambulatory care pharmacy practices. A pharmaceutical care program for patients with RAD was developed for use in community pharmacies.

Original languageEnglish (US)
Pages (from-to)791-796
Number of pages6
JournalAmerican Journal of Health-System Pharmacy
Volume58
Issue number9
StatePublished - May 1 2001

Fingerprint

Pharmaceutical Services
Pharmacists
Pharmacies
Job Satisfaction
Patient Education
Ambulatory Care

Keywords

  • Administration
  • Ambulatory care
  • Community
  • Education
  • Lung diseases
  • Pharmaceutical
  • Pharmaceutical care
  • Pharmaceutical services
  • Pharmacists
  • Pharmacy

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy

Cite this

Weinberger, M., Murray, M. D., Marrero, D. G., Brewer, N., Lykens, M., Harris, L. E., & Tierney, W. M. (2001). Pharmaceutical care program for patients with reactive airways disease. American Journal of Health-System Pharmacy, 58(9), 791-796.

Pharmaceutical care program for patients with reactive airways disease. / Weinberger, M.; Murray, M. D.; Marrero, D. G.; Brewer, N.; Lykens, M.; Harris, L. E.; Tierney, W. M.

In: American Journal of Health-System Pharmacy, Vol. 58, No. 9, 01.05.2001, p. 791-796.

Research output: Contribution to journalArticle

Weinberger, M, Murray, MD, Marrero, DG, Brewer, N, Lykens, M, Harris, LE & Tierney, WM 2001, 'Pharmaceutical care program for patients with reactive airways disease', American Journal of Health-System Pharmacy, vol. 58, no. 9, pp. 791-796.
Weinberger, M. ; Murray, M. D. ; Marrero, D. G. ; Brewer, N. ; Lykens, M. ; Harris, L. E. ; Tierney, W. M. / Pharmaceutical care program for patients with reactive airways disease. In: American Journal of Health-System Pharmacy. 2001 ; Vol. 58, No. 9. pp. 791-796.
@article{e64456eb51ad4ea3b6b2c3e84687d9b4,
title = "Pharmaceutical care program for patients with reactive airways disease",
abstract = "A pharmaceutical care program for patients with reactive airways disease (RAD) is described. A pharmaceutical care program for patients with RAD was developed and implemented at 36 CVS pharmacies. The impact on patient outcomes, pharmacist job satisfaction, and other variables is currently being evaluated in a controlled trial with more than 1100 patient enrollees. Guiding the program are the beliefs that pharmacists must have clinically relevant, patient-specific data to provide appropriate care; that pharmacists must have adequate training to provide pharmaceutical care; that the program must be sensitive to organizational barriers, particularly time demands; and that there must be ongoing support for the program. The program has five components: (1) computer display of patient-specific data for patients enrolled in the study, (2) distribution of tailored patient education materials, (3) use of a resource guide to facilitate the implementation of pharmaceutical care, (4) strategies to reinforce and facilitate the program, and (5) pharmacist training. While developed for community pharmacies, the program is applicable to most ambulatory care pharmacy practices. A pharmaceutical care program for patients with RAD was developed for use in community pharmacies.",
keywords = "Administration, Ambulatory care, Community, Education, Lung diseases, Pharmaceutical, Pharmaceutical care, Pharmaceutical services, Pharmacists, Pharmacy",
author = "M. Weinberger and Murray, {M. D.} and Marrero, {D. G.} and N. Brewer and M. Lykens and Harris, {L. E.} and Tierney, {W. M.}",
year = "2001",
month = "5",
day = "1",
language = "English (US)",
volume = "58",
pages = "791--796",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
publisher = "American Society of Health-Systems Pharmacy",
number = "9",

}

TY - JOUR

T1 - Pharmaceutical care program for patients with reactive airways disease

AU - Weinberger, M.

AU - Murray, M. D.

AU - Marrero, D. G.

AU - Brewer, N.

AU - Lykens, M.

AU - Harris, L. E.

AU - Tierney, W. M.

PY - 2001/5/1

Y1 - 2001/5/1

N2 - A pharmaceutical care program for patients with reactive airways disease (RAD) is described. A pharmaceutical care program for patients with RAD was developed and implemented at 36 CVS pharmacies. The impact on patient outcomes, pharmacist job satisfaction, and other variables is currently being evaluated in a controlled trial with more than 1100 patient enrollees. Guiding the program are the beliefs that pharmacists must have clinically relevant, patient-specific data to provide appropriate care; that pharmacists must have adequate training to provide pharmaceutical care; that the program must be sensitive to organizational barriers, particularly time demands; and that there must be ongoing support for the program. The program has five components: (1) computer display of patient-specific data for patients enrolled in the study, (2) distribution of tailored patient education materials, (3) use of a resource guide to facilitate the implementation of pharmaceutical care, (4) strategies to reinforce and facilitate the program, and (5) pharmacist training. While developed for community pharmacies, the program is applicable to most ambulatory care pharmacy practices. A pharmaceutical care program for patients with RAD was developed for use in community pharmacies.

AB - A pharmaceutical care program for patients with reactive airways disease (RAD) is described. A pharmaceutical care program for patients with RAD was developed and implemented at 36 CVS pharmacies. The impact on patient outcomes, pharmacist job satisfaction, and other variables is currently being evaluated in a controlled trial with more than 1100 patient enrollees. Guiding the program are the beliefs that pharmacists must have clinically relevant, patient-specific data to provide appropriate care; that pharmacists must have adequate training to provide pharmaceutical care; that the program must be sensitive to organizational barriers, particularly time demands; and that there must be ongoing support for the program. The program has five components: (1) computer display of patient-specific data for patients enrolled in the study, (2) distribution of tailored patient education materials, (3) use of a resource guide to facilitate the implementation of pharmaceutical care, (4) strategies to reinforce and facilitate the program, and (5) pharmacist training. While developed for community pharmacies, the program is applicable to most ambulatory care pharmacy practices. A pharmaceutical care program for patients with RAD was developed for use in community pharmacies.

KW - Administration

KW - Ambulatory care

KW - Community

KW - Education

KW - Lung diseases

KW - Pharmaceutical

KW - Pharmaceutical care

KW - Pharmaceutical services

KW - Pharmacists

KW - Pharmacy

UR - http://www.scopus.com/inward/record.url?scp=0035338195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035338195&partnerID=8YFLogxK

M3 - Article

C2 - 11351919

AN - SCOPUS:0035338195

VL - 58

SP - 791

EP - 796

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

SN - 1079-2082

IS - 9

ER -